Home / Ingredients / Vitamin C
Evidence reviewed: 2026-10-02
Essential nutrient with established physiological roles; routine supplementation does not prevent colds in the general population, though it may modestly shorten them.
Vitamin C is an essential nutrient. Regular supplementation generally does not prevent colds in the general population, but systematic reviews find modest reductions in cold duration and, in some analyses, severity. Starting vitamin C only after symptoms begin has not shown consistent benefit.
Common-cold evidence often examines regular intake of at least 200 mg/day, with larger effects in people exposed to extreme physical stress or with marginal vitamin C status.
High oral doses can cause diarrhea, nausea, and abdominal cramps. The adult tolerable upper intake level is 2,000 mg/day, and high doses can worsen iron overload in people with hemochromatosis.
Several current products list vitamin C, but most do not publish a dose that can be matched to specific trials. Ingredient presence supports a nutrient-content statement, not a finished-product cold, immune, collagen, or antioxidant efficacy claim.
Vitamin C for preventing and treating the common cold (Cochrane systematic review and meta-analysis; PMID 23440782)
Population/scope: 29 trial comparisons; 11,306 participants contributed to cold-incidence analyses
Evidence scope: Cold incidence, duration, and severity
Finding: Regular vitamin C did not materially reduce cold incidence in the general population but modestly shortened cold duration; therapeutic use after symptom onset was not consistently beneficial.
Limitations: Effects differed in people under extreme physical stress and by dosing context; findings should not be generalized to all immune claims.
Directness: Relevant human evidence · verified 2026-10-02
Important: Ingredient-level evidence is not proof that a finished product has the same effect. Dose, form, population, duration, and formulation must match.
For informational purposes only; not individualized medical advice.